Development of Biotinylated Liposomes Encapsulating Metformin for Therapeutic Targeting of Inflammation-Based Diseases

• Published in: Pharmaceutics Vol. 16; no. 2; p. 235
• Main Authors: Ailuno, Giorgia, Baldassari, Sara, Balboni, Alice, Pastorino, Sara, Zuccari, Guendalina, Cortese, Katia, Barbieri, Federica, Drava, Giuliana, Florio, Tullio, Caviglioli, Gabriele
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.02.2024; MDPI
• Subjects: Atherosclerosis; avidin–biotin complex; Cancer; Development and progression; Health aspects; Hydration; Inflammation; Lipids; liposomes; Metformin; Peptides; Polyethylene glycol; Pore size; Rheumatoid factor; targeting; Thin films; VCAM-1; Germany; United States > US; Spain; VCAM-1; targeting; inflammation; liposomes; avidin–biotin complex; metformin hydrochloride; cancer
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics16020235

Inflammation is a physiological response to a damaging stimulus but sometimes can be the cause of the onset of neurodegenerative diseases, atherosclerosis, and cancer. These pathologies are characterized by the overexpression of inflammatory markers like endothelial adhesion molecules, such as Vascular Cell Adhesion Molecule-1 (VCAM-1). In the present work, the development of liposomes for therapeutic targeted delivery to inflamed endothelia is described. The idea is to exploit a three-step pretargeting system based on the biotin-avidin high-affinity interaction: the first step involves a previously described biotin derivative bearing a VCAM-1 binding peptide; in the second step, the avidin derivative NeutrAvidin , which strongly binds to the biotin moiety, is injected; the final step is the administration of biotinylated liposomes that would bind to Neutravidin immobilized onto VCAM-1 overexpressing endothelium. Stealth biotinylated liposomes, prepared via the thin film hydration method followed by extrusion and purification via size exclusion chromatography, have been thoroughly characterized for their chemico-physical and morphological features and loaded with metformin hydrochloride, a potential anti-inflammatory agent. The three-step system, tested in vitro on different cell lines via confocal microscopy, FACS analysis and metformin uptake, has proved its suitability for therapeutic applications.